Nvidia Earnings in Focus China Chip Restrictions and Political Landscape Under Scrutiny Google Employee Faces Insider Trading Charges Over 12 Million in Bets Using Internal Data Novartis Lifts FullYear Sales and Profit Outlook Signaling Strong Operational Momentum Charter Communications Elevates Offer to Acquire Liberty Broadband in Revised Buyout Deal Jim Cramers Take on NVIDIA Ahead of Earnings Key Insights and Market Reactions Genpact CEO Warns of AIDriven Reduction in IT Workload and Jobs AIRI Q3 2025 Earnings NarrowerThanExpected Loss Drives Positive Surprise PEB Q1 2026 Earnings EPS Exceeds Estimates as Hotel REIT Navigates Challenging Environment Applied Industrial Technologies AIT Q1 2026 Earnings Slight EPS Miss as Margins Face Pressure SPRB Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount GLW Q1 2026 Earnings Earnings Slightly Beat Estimates Amid Operational Focus Cheesecake Factory CAKE Holds Above Key Support Amid Modest Gains MBIA Inc MBI Holds Steady Near Support as Shares Edge Higher Powell Industries POWL Surges 457 as Buying Pressure Intensifies Ensysce Biosciences ENSC Drops 3 as Stock Nears Support at 028 Plutus Financial Group PLUT Slips 226 as Stock Approaches Key Support at 288 AIInfrastructure and Energy Basket Outperforms Nvidia Doubling Investor Returns Lear Corporation LEA Q1 2026 Earnings Solid EPS Beat Drives Modest Share Gain Preformed Line Products PLPC Surges 39 as Momentum Builds Toward Key Resistance KOD Q1 2026 Earnings Narrower Loss on Lower Spending as Pipeline Progress Continues KOS Q1 2026 Earnings EPS Miss Weighs on Shares as Operating Environment Challenges Persist SBEV Q2 2025 Earnings WiderThanExpected Loss Drives Stock Down Over 4 VMD Q1 2026 Earnings EPS Misses Estimates but Positive Stock Response Signals Underlying Confidence RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition Genmab GMAB Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development